Journal for ImmunoTherapy of Cancer (Nov 2020)
377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects
- Nicholas Wilson,
- Richard Carvajal,
- Irina Shapiro,
- Anthony Tolcher,
- Dhan Chand,
- Marc Van Dijk,
- Anna Wijatyk,
- Jennifer Buell,
- James Strauss,
- Claire Galand,
- Vignesh Venkatraman,
- Marilyn Marques,
- Min Lim,
- Benjamin Morin,
- Olga Ignatovich,
- Mark Findeis,
- Dennis Underwood,
- Lernik Ohanjanian,
- David Savitsky
Affiliations
- Nicholas Wilson
- 5Gilead Sciences, San Carlos, CA, USA
- Richard Carvajal
- 3Columbia University Medical Center, New York, NY, USA
- Irina Shapiro
- 1Agenus Inc., Lexington, MA, USA
- Anthony Tolcher
- 6Next Onoclogy, San Antonio, TX, USA
- Dhan Chand
- 1Agenus Inc., Lexington, MA, USA
- Marc Van Dijk
- 4AgenTus Therapeutics, Inc., Cambridge, UK
- Anna Wijatyk
- 1Agenus Inc., Lexington, MA, USA
- Jennifer Buell
- 1Agenus Inc., Lexington, MA, USA
- James Strauss
- 2Mary Crowley Cancer Research Center, Dallas, TX, USA
- Claire Galand
- 1Agenus Inc., Lexington, MA, USA
- Vignesh Venkatraman
- 1Agenus Inc., Lexington, MA, USA
- Marilyn Marques
- 1Agenus Inc., Lexington, MA, USA
- Min Lim
- 1Agenus Inc., Lexington, MA, USA
- Benjamin Morin
- 1Agenus Inc., Lexington, MA, USA
- Olga Ignatovich
- 1Agenus Inc., Lexington, MA, USA
- Mark Findeis
- 1Agenus Inc., Lexington, MA, USA
- Dennis Underwood
- 1Agenus Inc., Lexington, MA, USA
- Lernik Ohanjanian
- 1Agenus Inc., Lexington, MA, USA
- David Savitsky
- 1Agenus Inc., Lexington, MA, USA
- DOI
- https://doi.org/10.1136/jitc-2020-SITC2020.0377
- Journal volume & issue
-
Vol. 8,
no. Suppl 3
Abstract
No abstracts available.
